Dallas, Texas
United States
43
2026-04-09
The entities that hold a legal rights for patent applications filed by inventor Olson Eric N.:
Eric N. Olson from Dallas, US has applied for patents for these inventions. The list has both pending applications and granted patents:
USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD
#2 | 2025-10-02COMPOSITIONS AND METHODS FOR MYOSIN HEAVY CHAIN BASE EDITING
#3 | 2024-10-03GENOMIC EDITING OF RBM20 MUTATIONS
#4 | 2024-07-11CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR
#5 | 2024-05-23NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING
#6 | 2022-03-10PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING
#7 | 2020-11-26COMPOSITIONS AND METHODS FOR CORRECTING DYSTROPHIN MUTATIONS IN HUMAN CARDIOMYOCYTES
#8 | 2020-06-18MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#9 | 2018-06-14Micro-RNA family that modulates extracellular matrix genes and uses thereof
#10 | 2016-09-08Modulation of MRTF-A activity in pathologic fibrosis and wound healing
#11 | 2016-05-26Micro-RNA family that modulates fibrosis and uses thereof
#12 | 2016-05-26Micro-RNA family that modulates fibrosis and uses thereof
#13 | 2016-05-26Micro-RNA family that modulates fibrosis and uses thereof
#14 | 2016-03-03PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING
#15 | 2015-10-29Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
#16 | 2014-08-07Compositions and Methods for Treating Skeletal Myopathy
#17 | 2014-06-26DUAL TARGETING OF MIR-208 AND MIR-499 IN THE TREATMENT OF CARDIAC DISORDERS
#18 | 2014-02-20Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair
#19 | 2014-01-09Antimir-451 for the treatment of polycythemias
#20 | 2013-10-03Micro-RNA family that modulates fibrosis and uses thereof
#21 | 2013-10-03Micro-RNA family that modulates fibrosis and uses thereof
#22 | 2013-09-19Micro-RNAS that control myosin expression and myofiber identity
#23 | 2013-08-01Micro-RNA family that modulates fibrosis and uses thereof
#24 | 2013-06-13Regulation of metabolism by miR-378
#25 | 2013-06-06Stem cell differentiating agents and uses therefor
#26 | 2013-01-03MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY
#27 | 2012-08-23Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
#28 | 2012-06-28Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure
#29 | 2012-02-02Stem cell differentiating agents and uses therefor
#30 | 2011-08-11MICRO-RNA THAT PROMOTES VASCULAR INTEGRITY AND USES THEREOF
#31 | 2010-08-19SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY
#32 | 2009-04-02Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
#33 | 2006-12-14Methods and compositions for therapeutic intervention in cardiac hypertrophy
#34 | 2006-07-04Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
#35 | 2006-03-30Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
#36 | 2006-02-28Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
#37 | 2006-02-02Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
#38 | 2005-12-22Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure
#39 | 2005-11-24Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
#40 | 2005-11-08Methods and compositions relating to a cardiac-specific nuclear regulatory factor
#41 | 2005-09-20Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
#42 | 2005-08-02Transgenic mice comprising a constitutively-activated MEK5 and exhibiting cardiac hypertrophy and dilated cardiomyopathy
#43 | 2005-05-19Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
13623 ⎘